PART I Company Overview We are a commercial stage biotechnology company focused on the research, development, and commercialization of innovative solutions for mens health and oncology. Through our acquisition of Proteomedix, which closed on December 15, 2023, we own Proclarix, an in vitro diagnostic test for prostate cancer originally developed by Proteomedix and approved for sale in the European Union under the In Vitro Diagnostic Regulation (IVDR), which we anticipate will be marketed in the ...
Q2 FY2026 — expected 2026-09-15
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-13 | 2025-12-31 | 0001213900-26-027725 | EDGAR | 120K words |
| 2025-06-02 | 2024-12-31 | 0001213900-25-049687 | EDGAR | — |
| 2024-04-11 | 2023-12-31 | 0001213900-24-032225 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001213900-23-018635 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001213900-22-016672 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-13 | 2025-09-30 | 0001213900-25-110142 | EDGAR | 44K words |
| 2025-08-14 | 2025-06-30 | 0001213900-25-076032 | EDGAR | — |
| 2025-06-12 | 2025-03-31 | 0001213900-25-053914 | EDGAR | — |
| 2024-12-10 | 2024-09-30 | 0001213900-24-107088 | EDGAR | — |
| 2024-08-29 | 2024-06-30 | 0001213900-24-073545 | EDGAR | — |
| 2024-05-20 | 2024-03-31 | 0001213900-24-045172 | EDGAR | — |
| 2023-11-17 | 2023-09-30 | 0001213900-23-088387 | EDGAR | — |
| 2023-10-20 | 2023-06-30 | 0001013762-23-005521 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0001213900-23-039141 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001213900-22-072376 | EDGAR | — |
| 2022-08-15 | 2022-06-30 | 0001213900-22-048105 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001213900-22-026516 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-29 | 0001213900-26-082879 | EDGAR | — |
| 2026-03-27 | 0001213900-26-034902 | EDGAR | 1K words |
| 2026-03-24 | 0001213900-26-033643 | EDGAR | — |
| 2026-02-12 | 0001213900-26-015212 | EDGAR | — |
| 2026-02-09 | 0001213900-26-013724 | EDGAR | — |
| 2025-12-10 | 0001213900-25-120144 | EDGAR | — |
| 2025-12-10 | 0001213900-25-119898 | EDGAR | — |
| 2025-10-29 | 0001213900-25-103351 | EDGAR | — |
| 2025-10-03 | 0001213900-25-095847 | EDGAR | — |
| 2025-09-26 | 0001213900-25-091966 | EDGAR | — |
171 total filings indexed. 144 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001782107 |
| Ticker | ONCO |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.onconetix.com |
| Listed | 2022-02-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/ONCO (~200 tokens, structured JSON with cryptographic provenance)